Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT00778375 · COMPLETED
Trial details
- NCT number
- NCT00778375
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2015-01-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.